๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Serum M3/M21 in ovarian cancer patients

โœ Scribed by Tempfer, C; Hefler, L; Haeusler, G; Sliutz, G; Hanzal, E; Reinthaller, A; Kainz, CH

Book ID
109837460
Publisher
Nature Publishing Group
Year
1997
Tongue
English
Weight
507 KB
Volume
76
Category
Article
ISSN
0007-0920

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Serum M3M21 in cervical cancer patients
Serum M3M21 in cervical cancer patients
โœ G. Sliutz; C. Tempfer; E. Hanzal; A. Reinthaller; H. Koelbl; R. Zeillinger; Ch. ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 315 KB
M3/M21 serum levels in women with adnexa
M3/M21 serum levels in women with adnexal masses and inflammatory diseases
โœ Lukas Hefler; Clemens Tempfer; Harald Heinzl; Guenther Haeusler; Petra Steindl; ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 72 KB

The aim of the present study was to evaluate the clinical usefulness of the cytokeratin tumor marker M3/M21 as a screening marker for ovarian cancer, as a predictive marker in patients with adnexal masses and as a prognostic factor in women with ovarian cancer. To determine the specificity of the M3

Serum MAGE-4 Protein in Ovarian Cancer P
Serum MAGE-4 Protein in Ovarian Cancer Patients
โœ Hidehiro Kawagoe; Akira Yamada; Hajime Matsumoto; Masaaki Ito; Kimio Ushijima; T ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 45 KB
Serum M-ficolin in children with cancer
Serum M-ficolin in children with cancer
โœ L.J. Schlapbach; S. Thiel; C. Aebi; A. Hirt; K. Leibundgut; J.C. Jensenius; R.A. ๐Ÿ“‚ Article ๐Ÿ“… 2010 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 74 KB